Targeting brain microvascular endothelial cells: a therapeutic approach to neuroprotection against stroke
Q Yu, H Tao, X Wang, M Li - Neural regeneration research, 2015 - journals.lww.com
Brain microvascular endothelial cells form the interface between nervous tissue and
circulating blood, and regulate central nervous system homeostasis. Brain microvascular …
circulating blood, and regulate central nervous system homeostasis. Brain microvascular …
Cyclic gmp in liver cirrhosis—role in pathophysiology of portal hypertension and therapeutic implications
W Kreisel, A Lazaro, J Trebicka… - International journal of …, 2021 - mdpi.com
The NO-cGMP signal transduction pathway plays a crucial role in tone regulation in hepatic
sinusoids and peripheral blood vessels. In a cirrhotic liver, the key enzymes endothelial NO …
sinusoids and peripheral blood vessels. In a cirrhotic liver, the key enzymes endothelial NO …
Exosomes derived from CXCR4‐overexpressing BMSC promoted activation of microvascular endothelial cells in cerebral ischemia/reperfusion injury
X Li, Y Zhang, Y Wang, D Zhao, C Sun, S Zhou… - Neural …, 2020 - Wiley Online Library
Background. Ischemic stroke is a severe acute cerebrovascular disease which can be
improved with neuroprotective therapies at an early stage. However, due to the lack of …
improved with neuroprotective therapies at an early stage. However, due to the lack of …
How to face chronic liver disease: the sinusoidal perspective
A Fernandez-Iglesias, J Gracia-Sancho - Frontiers in medicine, 2017 - frontiersin.org
Liver microcirculation plays an essential role in the progression and aggravation of chronic
liver disease. Hepatic sinusoid environment, mainly composed by hepatocytes, liver …
liver disease. Hepatic sinusoid environment, mainly composed by hepatocytes, liver …
Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
Abnormal angiogenesis is critical for portal hypertension in cirrhosis. Except for etiological
treatment, no efficient medication or regime has been explored to treat the early stage of …
treatment, no efficient medication or regime has been explored to treat the early stage of …
[HTML][HTML] Acute-on-chronic liver failure is independently associated with higher mortality for cirrhotic patients with acute esophageal variceal hemorrhage: Retrospective …
AZ Terres, RS Balbinot, ALF Muscope… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Acute esophageal variceal hemorrhage (AEVH) is a common complication
of cirrhosis and might precipitate multi-organ failure, causing acute-on-chronic liver failure …
of cirrhosis and might precipitate multi-organ failure, causing acute-on-chronic liver failure …
[HTML][HTML] Restructuring of the vascular bed in response to hemodynamic disturbances in portal hypertension
DV Garbuzenko, NO Arefyev… - World Journal of …, 2016 - ncbi.nlm.nih.gov
In recent years, defined progress has been made in understanding the mechanisms of
hemodynamic disturbances occurring in liver cirrhosis, which are based on portal …
hemodynamic disturbances occurring in liver cirrhosis, which are based on portal …
[HTML][HTML] Systemic hemodynamics in advanced cirrhosis: Concerns during perioperative period of liver transplantation
T Hori, Y Ogura, Y Onishi, H Kamei… - World journal of …, 2016 - ncbi.nlm.nih.gov
Advanced liver cirrhosis is usually accompanied by portal hypertension. Long-term portal
hypertension results in various vascular alterations. The systemic hemodynamic state in …
hypertension results in various vascular alterations. The systemic hemodynamic state in …
Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension
W Kreisel, D Schaffner, A Lazaro, J Trebicka… - International Journal of …, 2020 - mdpi.com
Liver cirrhosis is a frequent condition with high impact on patients' life expectancy and health
care systems. Cirrhotic portal hypertension (PH) gradually develops with deteriorating liver …
care systems. Cirrhotic portal hypertension (PH) gradually develops with deteriorating liver …
Emerging therapies for portal hypertension in cirrhosis
H Nair, A Berzigotti, J Bosch - Expert opinion on emerging drugs, 2016 - Taylor & Francis
Introduction: Counteracting splanchnic vasodilatation and increased portal-collateral blood
flow has been the mainstay for the treatment of portal hypertension (PH) over the past three …
flow has been the mainstay for the treatment of portal hypertension (PH) over the past three …